An observational study in Cardiogenic Shock, sponsored by New Brunswick Heart Centre. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2022-06-10.
Sponsored by New Brunswick Heart Centre · Observational
In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC).
The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.
277 studies on the registry are indexed under Shock, Cardiogenic; 127 are open to participants now.
This study's enrollment of 1,416 is above the median of 200 across 142 observational studies indexed under Shock, Cardiogenic.
Browse Shock, Cardiogenic studies →New Brunswick Heart Centre is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients who were admitted to the CCU at the NBHC, Saint John Regional Hospital between November 1st 2019 to November 30th 2020 were included in the study.
Exclusion Criteria:
Patients who had a SCAI stage A or B at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was compared with the cardiogenic shock group only for preliminary analysis.
Other: Standard care
Patients who had a SCAI (Society for Cardiovascular Angiography and Interventions) stage C-E at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was used for all subsequent analyses.
Other: Standard care
No interventions were used, as this is an observational study.
Percentage mortality
Any in-hospital mortality (within Saint John Regional Hospital, another hospital after transfer)
Time frame: From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Length of stay (LOS))
LOS was considered only for patients who were discharged directly home from Saint John Regional Hospital
Time frame: From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Discharge disposition
Discharge of patients home, transfer to another hospital or to another institution (special care home, extra-mural home)
Time frame: From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Percentage of missed opportunities
Missed opportunities was defined as patients who suffered significant delays or those who did not receive any intervention
Time frame: From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Time from diagnosis of shock to in-hospital processes
Time gaps between the first diagnosis of a cardiogenic shock to in-hospital processes like invasive monitoring, cardiac catheterization or interventions (surgery, PCI, TAVI, IABP or ECMO).
Time frame: From the date of hospital admission at Saint John Regional Hospital to the date of discharge, assessed upto 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
New Brunswick Heart Centre